Eyepoint Pharmaceuticals Inc (EYPT) — Free Cash Flow Generation Index
Eyepoint Pharmaceuticals Inc (EYPT) has a Free Cash Flow Generation Index of 0.99x as of June 2023. Free cash flow of $56.63 Million represents 1% of operating cash flow ($57.02 Million). See working capital to net assets of Eyepoint Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eyepoint Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2023)
Historical FCF Generation Index trend for Eyepoint Pharmaceuticals Inc across 3 annual periods. Explore Eyepoint Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Eyepoint Pharmaceuticals Inc (2010–2023)
Year-by-year Free Cash Flow Generation Index for Eyepoint Pharmaceuticals Inc. For the full company profile including market capitalisation, see Eyepoint Pharmaceuticals Inc market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.86x | $-1.61 Million | $1.88 Million | $3.48 Million | ▼ -187.1% |
| 2015 | 0.98x | $10.14 Million | $10.30 Million | $161.00K | ▼ -1.4% |
| 2010 | 1.00x | $9.88 Million | $9.90 Million | $15.00K | — |